Surgical applications of drug delivery systems
The current research group is a multidisciplinary team that allows it to address different areas of interest focused on experimental and translational surgery. The research group is focused on the development of biodegradable drug-eluting devices through polymeric matrices, which allow local drug instillation, allowing greater precision and reduction in the dose of the active ingredient. Another important research activity is focused on the development of cardiac devices, mainly on the design of a definitive artificial implantable ventricle. The group's activity is focused on the research projects they are implementing in these two research activities.
2025 ACTIVITY INDICATORS
- 1 competitive national public project: ISCIII
- 1 competitive private project
- 1 clinical study
- 9 publications
- IF: 20.40
- Publications in Q1: 2 (33%)
- 3 awards
- Project evaluator: 1 PI
- Editorial committee member: 1 PI
- 1 PCT application/ES2023/070325 "Biodegradable, self-retaining, antireflux intraureteral stent" with international scope in Europe, the USA, and Canada.
- 3 visiting researchers and 7-month stay: Polytechnic University of Madrid
Milestones
- The BraidStent project, led by Dr. Federico Soria, was selected for the "Venture Building - Opportunity Validation" transfer program, organized by The Collider as part of Mobile World Capital Barcelona.
- Participation in the Young Researchers Program of the Community of Madrid facilitated the addition of Mariángélica González Aranguren to contribute to the development of animal models of pathology, ex vivo surgical simulation for training, and the strengthening of research and animal facility management activities, including highly specialized areas such as immunosuppressed animals and the zebrafish unit.
- A patent application, PCT/IB2023/000230, for a "Biodegradable, self-retentive and anti-reflux intra-ureteral stent," was filed in Europe, the United States, and Canada.
- Award of a Technological Development Project (DTS25/00041) "Biodegradable, Drug-Eluting Ureteral Stent for the Adjuvant Treatment of Urothelial Carcinoma," AES2025, funded by the ISCIII, to enhance the project's technological maturity.
- Collaboration agreement with the Tecniker Technology Park for the development and prototyping of the VIDA (Artificial Definitive Left Ventricle) project, led by Dr. Javier Miguelena.
